Hydroxychloroquine, Interleukin-6 Receptor Antagonists and Corticoid Treatments of Acute COVID-19 Infection: Psychiatric Symptoms and Mental Disorders 4 Months Later

OBJECTIVE: Psychiatric symptoms and mental disorders are common after Coronavirus Disease-19 (COVID-19). Some drugs used to treat acute COVID-19 have psychiatric side effects. We assessed the psychiatric symptoms and mental disorders of patients treated for acute COVID-19 with hydroxychloroquine (HC...

Descripción completa

Detalles Bibliográficos
Autores principales: Gasnier, Matthieu, Choucha, Walid, Montani, David, Noël, Nicolas, Verstuyft, Céline, Radiguer, Francois, Monnet, Xavier, Becquemont, Laurent, Corruble, Emmanuelle, Colle, Romain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606425/
https://www.ncbi.nlm.nih.gov/pubmed/36263650
http://dx.doi.org/10.9758/cpn.2022.20.4.762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606425/
https://www.ncbi.nlm.nih.gov/pubmed/36263650
http://dx.doi.org/10.9758/cpn.2022.20.4.762

Ejemplares similares